Aldosterone in the brain

American Journal of Physiology - Renal Physiology

Volumn 297, Issue 3, 2009, Pages

  Geerling, Joel C ^a   Loewy, Arthur D ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

11 hydroxysteroid dehydrogenase; Blood brain barrier; Glucocorticoids; Mineralocorticoids; Nucleus of the solitary tract; Sodium deficiency

Indexed keywords

11BETA HYDROXYSTEROID DEHYDROGENASE 1; 11BETA HYDROXYSTEROID DEHYDROGENASE 2; ALDOSTERONE; CORTICOSTERONE; ESTRADIOL; GLUCOCORTICOID; HYDROCORTISONE; MESSENGER RNA; MINERALOCORTICOID; MINERALOCORTICOID RECEPTOR; PROGESTERONE; TESTOSTERONE;

BLOOD BRAIN BARRIER; BLOOD PRESSURE; BRAIN; BRAIN FOURTH VENTRICLE; BRAIN NERVE CELL; CENTRAL NERVOUS SYSTEM; ENZYME ACTIVITY; HORMONE ACTION; HORMONE SYNTHESIS; HUMAN; HYPOTHALAMUS NUCLEUS; NEUROPHYSIOLOGY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; REVIEW; SODIUM DEFICIENCY; SOLITARY TRACT NUCLEUS;

EID: 69449089275     PISSN: 1931857X     EISSN: 15221466     Source Type: Journal    
DOI: 10.1152/ajprenal.90399.2008     Document Type: Review

References (193)

1. Abrams JM, Osborn JW. A role for benzamil-sensitive proteins of the central nervous system in the pathogenesis of salt-dependent hypertension. Clin Exp Pharmacol Physiol 35: 687-694, 2008.
2. Agarwal AK, Monder C, Eckstein B, White PC. Cloning and expression of rat cDNA encoding corticosteroid 11β-dehydrogenase. J Biol Chem 264: 18939-18943, 1989. (Pubitemid 19285795)
3. +-dependent isoform of 11β-hydroxysteroid dehydrogenase. Cloning and characterization of cDNA from sheep kidney. J Biol Chem 269: 25959-25962, 1994.
4. Agarwal MK, Mirshahi F, Mirshahi M, Rostene W. Immunochemical detection of the mineralocorticoid receptor in rat brain. Neuroendocrinology 58: 575-580, 1993. (Pubitemid 23343941)
5. Ahima R, Krozowski Z, Harlan R. Type I corticosteroid receptor-like immunoreactivity in the rat CNS: distribution and regulation by corticosteroids. J Comp Neurol 313: 522-538, 1991.
6. Ahokoski O, Virtanen A, Kairisto V, Scheinin H, Huupponen R, Irjala K. Biological day-to-day variation and reference change limits of serum cortisol and aldosterone in healthy young men on unrestricted diets. Clin Chem 45: 1097-1099, 1999. (Pubitemid 29340553)
7. Armanini D, Karbowiak I, Funder JW. Affinity of liquorice derivatives for mineralocorticoid and glucocorticoid receptors. Clin Endocrinol (Oxf) 19: 609-612, 1983. (Pubitemid 14226000)
8. Armanini D, Karbowiak I, Krozowski Z, Funder JW, Adam WR. The mechanism of mineralocorticoid action of carbenoxolone. Endocrinology 111: 1683-1686, 1982.
9. Arriza JL, Simerly RB, Swanson LW, Evans RM. The neuronal mineralocorticoid receptor as a mediator of glucocorticoid response. Neuron 1: 887-900, 1988.
10. Atarashi K, Matsuoka H, Takagi M, Yamada K, Hirata Y, Hayakawa H, Sugimoto T. Effects of intracerebroventricular infusion of aldosterone on blood pressure and sodium and potassium concentrations in cerebral spinal fluid in rats. Clin Exp Hypertens A 10 Suppl 1: 317-322, 1988. (Pubitemid 19078429)
11. August JT, Nelson DH, Thorn GW. Response of normal subjects to large amounts of aldosterone. J Clin Invest 37: 1549-1555, 1958.
12. Bailey MA, Paterson JM, Hadoke PW, Wrobel N, Bellamy CO, Brownstein DG, Seckl JR, Mullins JJ. A switch in the mechanism of hypertension in the syndrome of apparent mineralocorticoid excess. J Am Soc Nephrol 19: 47-58, 2008.
13. Beaumont K, Fanestil DD. Characterization of rat brain aldosterone receptors reveals high affinity for corticosterone. Endocrinology 113: 2043-2051, 1983. (Pubitemid 14213567)
14. Birmingham MK, Sar M, Stumpf WE. Localization of aldosterone and corticosterone in the central nervous system, assessed by quantitative autoradiography. Neurochem Res 9: 333-350, 1984. (Pubitemid 14086521)
15. Birmingham MK, Stumpf WE, Sar M. Nuclear localization of aldosterone in rat brain cells assessed by autoradiography. Experientia 35: 1240-1241, 1979. (Pubitemid 10219552)
16. Broadwell RD, Sofroniew MV. Serum proteins bypass the blood-brain fluid barriers for extracellular entry to the central nervous system. Exp Neurol 120: 245-263, 1993.
17. Brody MJ. Central nervous system and mechanisms of hypertension. Clin Physiol Biochem 6: 230-239, 1988. (Pubitemid 18162493)
18. Brown RW, Diaz R, Robson AC, Kotelevtsev YV, Mullins JJ, Kaufman MH, Seckl JR. The ontogeny of 11β-hydroxysteroid dehydrogenase type 2 and mineralocorticoid receptor gene expression reveal intricate control of glucocorticoid action in development. Endocrinology 137: 794-797, 1996. (Pubitemid 26049889)
19. Bunag RD, Miyajima E. Sympathetic hyperactivity elevates blood pressure during acute cerebroventricular infusions of hypertonic salt in rats. J Cardiovasc Pharmacol 6: 844-851, 1984. (Pubitemid 14023336)
20. Campbell LE, Yu M, Yang K. Ovine 11β-hydroxysteroid dehydrogenase type 2 gene predicts a protein distinct from that deduced by the cloned kidney cDNA at the C-terminus. Mol Cell Endocrinol 119: 113-118, 1996. (Pubitemid 26181421)
21. Canteras NS, Simerly RB, Swanson LW. Organization of projections from the ventromedial nucleus of the hypothalamus: a Phaseolus vulgaris-leucoagglutinin study in the rat. J Comp Neurol 348: 41-79, 1994. (Pubitemid 24294679)
22. Chamberlin NL, Saper CB. Topographic organization of cardiovascular responses to electrical and glutamate microstimulation of the parabrachial nucleus in the rat. J Comp Neurol 326: 245-262, 1992.
23. Chan RK, Sawchenko PE. Organization and transmitter specificity of medullary neurons activated by sustained hypertension: implications for understanding baroreceptor reflex circuitry. J Neurosci 18: 371-387, 1998.
24. Choudhuri S, Cherrington NJ, Li N, Klaassen CD. Constitutive expression of various xenobiotic and endobiotic transporter mRNAs in the choroid plexus of rats. Drug Metab Dispos 31: 1337-1345, 2003. (Pubitemid 37310322)
25. Ciriello J, Janssen SA. Effect of glutamate stimulation of bed nucleus of the stria terminalis on arterial pressure and heart rate. Am J Physiol Heart Circ Physiol 265: H1516-H1522, 1993. (Pubitemid 23348180)
26. Ciriello J, Solano-Flores LP, Rosas-Arellano MP, Kirouac GJ, Babic T. Medullary pathways mediating the parasubthalamic nucleus depressor response. Am J Physiol Regul Integr Comp Physiol 294: R1276-R1284, 2008.
27. Coirini H, Magarinos AM, De Nicola AF, Rainbow TC, McEwen BS. Further studies of brain aldosterone binding sites employing new mineralocorticoid and glucocorticoid receptor markers in vitro. Brain Res 361: 212-216, 1985. (Pubitemid 16185402)
28. Cole TJ. Cloning of the mouse 11β-hydroxysteroid dehydrogenase type 2 gene: tissue specific expression and localization in distal convoluted tubules and collecting ducts of the kidney. Endocrinology 136: 4693-4696, 1995.
29. Connell JM, Davies E. The new biology of aldosterone. J Endocrinol 186: 1-20, 2005.
30. Coolen LM, Peters HJ, Veening JG. Fos immunoreactivity in the rat brain following consummatory elements of sexual behavior: a sex comparison. Brain Res 738: 67-82, 1996.
31. Cooney AS, Fitzsimons JT. Increased sodium appetite and thirst in rat induced by the ingredients of liquorice, glycyrrhizic acid and glycyrrhetinic acid. Regul Pept 66: 127-133, 1996.
32. Davis M, Shi C. The extended amygdala: are the central nucleus of the amygdala and the bed nucleus of the stria terminalis differentially involved in fear versus anxiety? Ann NY Acad Sci 877: 281-291, 1999. (Pubitemid 29351863)
33. 22Na in the cerebrospinal fluid and the brain. J Physiol 209: 131-153, 1970.
34. de Kloet ER, Van Acker SA, Sibug RM, Oitzl MS, Meijer OC, Rahmouni K, de Jong W. Brain mineralocorticoid receptors and centrally regulated functions. Kidney Int 57: 1329-1336, 2000. (Pubitemid 30207887)
35. Delfs JM, Zhu Y, Druhan JP, Aston-Jones G. Noradrenaline in the ventral forebrain is critical for opiate withdrawal-induced aversion. Nature 403: 430-434, 2000. (Pubitemid 30073092)
36. Devenport LD, Torres A, Murray CG. Effects of aldosterone and deoxycorticosterone on food intake and body weight. Behav Neurosci 97: 667-669, 1983.
37. Diaz R, Brown RW, Seckl JR. Distinct ontogeny of glucocorticoid and mineralocorticoid receptor and 11β-hydroxysteroid dehydrogenase types I and II mRNAs in the fetal rat brain suggest a complex control of glucocorticoid actions. J Neurosci 18: 2570-2580, 1998. (Pubitemid 28141804)
38. Douglas J, Catt KJ. Regulation of angiotensin II receptors in the rat adrenal cortex by dietary electrolytes. J Clin Invest 58: 834-843, 1976.
39. Dundore RL, Wurpel JN, Balaban CD, Keil LC, Severs WB. Central effects of aldosterone infused into the rat subcommissural organ region. Neurosci Res 1: 341-351, 1984.
40. Duvernoy HM, Risold PY. The circumventricular organs: an atlas of comparative anatomy and vascularization. Brain Res Rev 56: 119-147, 2007.
41. Dymecki SM, Kim JC. Molecular neuroanatomy's "three Gs": a primer. Neuron 54: 17-34, 2007.
42. Edwards CR, Stewart PM, Burt D, Brett L, McIntyre MA, Sutanto WS, de Kloet ER, Monder C. Localisation of 11β-hydroxysteroid dehydrogenase - tissue specific protector of the mineralocorticoid receptor. Lancet 2: 986-989, 1988. (Pubitemid 18254266)
43. Emanuele E, Geroldi D, Minoretti P, Coen E, Politi P. Increased plasma aldosterone in patients with clinical depression. Arch Med Res 36: 544-548, 2005. (Pubitemid 41140063)
44. Fejes-Toth G, Pearce D, Naray-Fejes-Toth A. Subcellular localization of mineralocorticoid receptors in living cells: effects of receptor agonists and antagonists. Proc Natl Acad Sci USA 95: 2973-2978, 1998. (Pubitemid 28135839)
45. Fiebeler A, Nussberger J, Shagdarsuren E, Rong S, Hilfenhaus G, Al-Saadi N, Dechend R, Wellner M, Meiners S, Maser-Gluth C, Jeng AY, Webb RL, Luft FC, Muller DN. Aldosterone synthase inhibitor ameliorates angiotensin II-induced organ damage. Circulation 111: 3087-3094, 2005. (Pubitemid 40847786)
46. Fluharty SJ, Epstein AN. Sodium appetite elicited by intracerebroventricular infusion of angiotensin II in the rat. II. Synergistic interaction with systemic mineralocorticoids. Behav Neurosci 97: 746-758, 1983. (Pubitemid 14249069)
47. Francis J, Weiss RM, Wei SG, Johnson AK, Beltz TG, Zimmerman K, Felder RB. Central mineralocorticoid receptor blockade improves volume regulation and reduces sympathetic drive in heart failure. Am J Physiol Heart Circ Physiol 281: H2241-H2251, 2001. (Pubitemid 33121771)
48. Fregly MJ, Waters IW. Effect of mineralocorticoids on spontaneous sodium chloride appetite of adrenalectomized rats. Physiol Behav 1: 65-74, 1966.
49. Funder J, Myles K. Exclusion of corticosterone from epithelial mineralocorticoid receptors is insufficient for selectivity of aldosterone action: in vivo binding studies. Endocrinology 137: 5264-5268, 1996. (Pubitemid 26423083)
50. Funder JW. Central effects of mineralocorticoids on blood pressure: new answers, new questions. J Hypertens 20: 1715-1716, 2002. (Pubitemid 35041957)
51. Funder JW. Aldosterone, mineralocorticoid receptors and vascular inflammation. Mol Cell Endocrinol 217: 263-269, 2004.
52. Funder JW, Pearce PT, Smith R, Smith AI. Mineralocorticoid action: target tissue specificity is enzyme, not receptor, mediated. Science 242: 583-585, 1988. (Pubitemid 18263202)
53. Geerling JC, Chimenti PC, Loewy AD. Phox2b expression in the aldosterone-sensitive HSD2 neurons of the NTS. Brain Res 1226: 82-88, 2008.
54. Geerling JC, Engeland WC, Kawata M, Loewy AD. Aldosterone target neurons in the nucleus tractus solitarius drive sodium appetite. J Neurosci 26: 411-417, 2006. (Pubitemid 43237104)
55. Geerling JC, Kawata M, Loewy AD. Aldosterone-sensitive neurons in the rat central nervous system. J Comp Neurol 494: 515-527, 2006. (Pubitemid 41790999)
56. Geerling JC, Loewy AD. Aldosterone-sensitive neurons in the nucleus of the solitary tract: bidirectional connections with the central nucleus of the amygdala. J Comp Neurol 497: 646-657, 2006.
57. Geerling JC, Loewy AD. Aldosterone-sensitive neurons in the nucleus of the solitary tract: efferent projections. J Comp Neurol 497: 223-250, 2006. (Pubitemid 43825429)
58. Geerling JC, Loewy AD. Aldosterone-sensitive NTS neurons are inhibited by saline ingestion during chronic mineralocorticoid treatment. Brain Res 1115: 54-64, 2006.
59. Geerling JC, Loewy AD. 11β-Hydroxysteroid dehydrogenase 2 vs. transgene: discrepant loci of expression in the adult brain. Am J Physiol Renal Physiol 293: F440-F443, 2007.
60. Geerling JC, Loewy AD. Sodium depletion activates the aldosterone-sensitive neurons in the NTS independently of thirst. Am J Physiol Regul Integr Comp Physiol 292: R1338-R1348, 2007.
61. Geerling JC, Loewy AD. Sodium deprivation and salt intake activate separate neuronal subpopulations in the nucleus of the solitary tract and the parabrachial complex. J Comp Neurol 504: 379-403, 2007.
62. Geerling JC, Loewy AD. Central regulation of sodium appetite. Exp Physiol 93: 177-209, 2008.
63. Geerling JC, Mettenleiter TC, Loewy AD. Orexin neurons project to diverse sympathetic outflow systems. Neuroscience 122: 541-550, 2003.
64. Gerlach JL, McEwen BS. Rat brain binds adrenal steroid hormone: radioautography of hippocampus with corticosterone. Science 175: 1133-1136, 1972.
65. Gomez-Sanchez CE, de Rodriguez AF, Romero DG, Estess J, Warden MP, Gomez-Sanchez MT, Gomez-Sanchez EP. Development of a panel of monoclonal antibodies against the mineralocorticoid receptor. Endocrinology 147: 1343-1348, 2006. (Pubitemid 43244368)
66. Gomez-Sanchez CE, Zhou MY, Cozza EN, Morita H, Eddleman FC, Gomez-Sanchez EP. Corticosteroid synthesis in the central nervous system. Endocr Res 22: 463-470, 1996. (Pubitemid 26424363)
67. Gomez-Sanchez CE, Zhou MY, Cozza EN, Morita H, Foecking MF, Gomez-Sanchez EP. Aldosterone biosynthesis in the rat brain. Endocrinology 138: 3369-3373, 1997. (Pubitemid 27345690)
68. Gomez-Sanchez EP. Intracerebroventricular infusion of aldosterone induces hypertension in rats. Endocrinology 118: 819-823, 1986. (Pubitemid 16162807)
69. Gomez-Sanchez EP. Central hypertensive effects of aldosterone. Front Neuroendocrinol 18: 440-462, 1997.
70. Gomez-Sanchez EP, Ahmad N, Romero DG, Gomez-Sanchez CE. Is aldosterone synthesized within the rat brain? Am J Physiol Endocrinol Metab 288: E342-E346, 2005. (Pubitemid 40110641)
71. Gomez-Sanchez EP, Fort C, Thwaites D. Central mineralocorticoid receptor antagonism blocks hypertension in Dahl S/JR rats. Am J Physiol Endocrinol Metab 262: E96-E99, 1992.
72. Gomez-Sanchez EP, Fort CM, Gomez-Sanchez CE. Intracerebroventricular infusion of RU28318 blocks aldosterone-salt hypertension. Am J Physiol Endocrinol Metab 258: E482-E484, 1990.
73. Gomez-Sanchez EP, Gomez-Sanchez CE. Central hypertensinogenic effects of glycyrrhizic acid and carbenoxolone. Am J Physiol Endocrinol Metab 263: E1125-E1130, 1992.
74. Gomez-Sanchez EP, Samuel J, Vergara G, Ahmad N. Effect of 3β-hydroxysteroid dehydrogenase inhibition by trilostane on blood pressure in the Dahl salt-sensitive rat. Am J Physiol Regul Integr Comp Physiol 288: R389-R393, 2005. (Pubitemid 40129603)
75. Gomez-Sanchez EP, Venkataraman MT, Thwaites D, Fort C. ICV infusion of corticosterone antagonizes ICV-aldosterone hypertension. Am J Physiol Endocrinol Metab 258: E649-E653, 1990. (Pubitemid 20142346)
76. Grippo AJ, Moffitt JA, Beltz TG, Johnson AK. Reduced hedonic behavior and altered cardiovascular function induced by mild sodium depletion in rats. Behav Neurosci 120: 1133-1143, 2006.
77. Groc L, Choquet D, Chaouloff F. The stress hormone corticosterone conditions AMPAR surface trafficking and synaptic potentiation. Nat Neurosci 11: 868-870, 2008.
78. Gross PM, Wall KM, Pang JJ, Shaver SW, Wainman DS. Microvascular specializations promoting rapid interstitial solute dispersion in nucleus tractus solitarius. Am J Physiol Regul Integr Comp Physiol 259: R1131-R1138, 1990.
79. Hade JS, Mifflin SW, Donta TS, Felder RB. Stimulation of parabrachial neurons elicits a sympathetically mediated pressor response in cats. Am J Physiol Heart Circ Physiol 255: H1349-H1358, 1988.
80. Han F, Ozawa H, Matsuda K, Nishi M, Kawata M. Colocalization of mineralocorticoid receptor and glucocorticoid receptor in the hippocampus and hypothalamus. Neurosci Res 51: 371-381, 2005. (Pubitemid 40299325)
81. Hlavacova N, Jezova D. Chronic treatment with the mineralocorticoid hormone aldosterone results in increased anxiety-like behavior. Horm Behav 54: 90-97, 2008.
82. Hoffman GE, Smith MS, Verbalis JG. c-Fos and related immediate early gene products as markers of activity in neuroendocrine systems. Front Neuroendocrinol 14: 173-213, 1993.
83. Holmes MC, Sangra M, French KL, Whittle IR, Paterson J, Mullins JJ, Seckl JR. 11β-Hydroxysteroid dehydrogenase type 2 protects the neonatal cerebellum from deleterious effects of glucocorticoids. Neuroscience 137: 865-873, 2006. (Pubitemid 43053950)
84. Holmes MC, Seckl JR. The role of 11β-hydroxysteroid dehydrogenases in the brain. Mol Cell Endocrinol 248: 9-14, 2006.
85. Huang BS, Amin MS, Leenen FH. The central role of the brain in salt-sensitive hypertension. Curr Opin Cardiol 21: 295-304, 2006.
86. + in Dahl salt-sensitive vs. -resistant rats. Am J Physiol Heart Circ Physiol 281: H1881-H1889, 2001.
87. + in Wistar rats. Am J Physiol Regul Integr Comp Physiol 295: R166-R172, 2008.
88. Ingram MC, Wallace AM, Collier A, Fraser R, Connell JM. Sodium status, corticosteroid metabolism and blood pressure in normal human subjects and in a patient with abnormal salt appetite. Clin Exp Pharmacol Physiol 23: 375-378, 1996. (Pubitemid 26168758)
89. Ito T, Morita N, Nishi M, Kawata M. In vitro and in vivo immunocytochemistry for the distribution of mineralocorticoid receptor with the use of specific antibody. Neurosci Res 37: 173-182, 2000. (Pubitemid 30625006)
90. Jalowiec JE, Stricker EM. Sodium appetite in adrenalectomized rats following dietary sodium deprivation. J Comp Physiol Psychol 82: 66-77, 1973.
91. Janiak PC, Lewis SJ, Brody MJ. Role of central mineralocorticoid binding sites in development of hypertension. Am J Physiol Regul Integr Comp Physiol 259: R1025-R1034, 1990.
92. Jellinck PH, Monder C, McEwen BS, Sakai RR. Differential inhibition of 11β-hydroxysteroid dehydrogenase by carbenoxolone in rat brain regions and peripheral tissues. J Steroid Biochem Mol Biol 46: 209-213, 1993. (Pubitemid 23251679)
93. Johnson AK, de Olmos J, Pastuskovas CV, Zardetto-Smith AM, Vivas L. The extended amygdala and salt appetite. Ann NY Acad Sci 877: 258-280, 1999.
94. Kageyama Y, Bravo EL. Hypertensive mechanisms associated with centrally administered aldosterone in dogs. Hypertension 11: 750-753, 1988. (Pubitemid 18189603)
95. Kageyama Y, Suzuki H, Saruta T. Presence of aldosterone-like immunoreactivity in cerebrospinal fluid in normotensive subjects. Acta Endocrinol 126: 501-504, 1992.
96. Kang BJ, Chang DA, Mackay DD, West GH, Moreira TS, Takakura AC, Gwilt JM, Guyenet PG, Stornetta RL. Central nervous system distribution of the transcription factor Phox2b in the adult rat. J Comp Neurol 503: 627-641, 2007. (Pubitemid 47184581)
97. Karst H, Berger S, Turiault M, Tronche F, Schutz G, Joels M. Mineralocorticoid receptors are indispensable for nongenomic modulation of hippocampal glutamate transmission by corticosterone. Proc Natl Acad Sci USA 102: 19204-19207, 2005. (Pubitemid 43049590)
98. Kawano Y, Ferrario CM. Neurohormonal characteristics of cardiovascular response due to intraventricular hypertonic NaCl. Am J Physiol Heart Circ Physiol 247: H422-H428, 1984. (Pubitemid 14047355)
99. Kayaba Y, Nakamura A, Kasuya Y, Ohuchi T, Yanagisawa M, Komuro I, Fukuda Y, Kuwaki T. Attenuated defense response and low basal blood pressure in orexin knockout mice. Am J Physiol Regul Integr Comp Physiol 285: R581-R593, 2003. (Pubitemid 37040566)
100. Khurshid KA, Weaver ME. Conn's syndrome presenting as depression. Am J Psychiatry 162: 1226, 2005.
101. Klarr SA, Keep RF, Betz AL. Chronic central potassium infusion prevents deoxycorticosterone-salt hypertension in rats. Am J Physiol Heart Circ Physiol 268: H646-H652, 1995.
102. Kotelevtsev Y, Brown RW, Fleming S, Kenyon C, Edwards CR, Seckl JR, Mullins JJ. Hypertension in mice lacking 11β-hydroxysteroid dehydrogenase type 2. J Clin Invest 103: 683-689, 1999. (Pubitemid 29122421)
103. Kotelevtsev Y, Holmes MC, Burchell A, Houston PM, Schmoll D, Jamieson P, Best R, Brown R, Edwards CR, Seckl JR, Mullins JJ. 11β-Hydroxysteroid dehydrogenase type 1 knockout mice show attenuated glucocorticoid-inducible responses and resist hyperglycemia on obesity or stress. Proc Natl Acad Sci USA 94: 14924-14929, 1997. (Pubitemid 28041476)
104. Kraulis I, Foldes G, Traikov H, Dubrovsky B, Birmingham. Distribution, metabolism and biological activity of deoxycorticosterone in the central nervous system. Brain Res 88: 1-14, 1975.
105. Krozowski ZS, Funder JW. Renal mineralocorticoid receptors and hippocampal corticosterone-binding species have identical intrinsic steroid specificity. Proc Natl Acad Sci USA 80: 6056-6060, 1983.
106. Kumar NN, Goodchild AK, Li Q, Pilowsky PM. An aldosteronerelated system in the ventrolateral medulla oblongata of spontaneously hypertensive and Wistar-Kyoto rats. Clin Exp Pharmacol Physiol 33: 71-75, 2006.
107. Lakshmi V, Monder C. Purification and characterization of the corticosteroid 11β-dehydrogenase component of the rat liver 11β-hydroxysteroid dehydrogenase complex. Endocrinology 123: 2390-2398, 1988. (Pubitemid 18255399)
108. Lakshmi V, Sakai RR, McEwen BS, Monder C. Regional distribution of 11β-hydroxysteroid dehydrogenase in rat brain. Endocrinology 128: 1741-1748, 1991.
109. Latif SA, Conca TJ, Morris DJ. The effects of the licorice derivative, glycyrrhetinic acid, on hepatic 3α- and 3β-hydroxysteroid dehydrogenases and 5α- and 5β- reductase pathways of metabolism of aldosterone in male rats. Steroids 55: 52-58, 1990.
110. Lee G, Makhanova N, Caron K, Lopez ML, Gomez RA, Smithies O, Kim HS. Homeostatic responses in the adrenal cortex to the absence of aldosterone in mice. Endocrinology 146: 2650-2656, 2005. (Pubitemid 40695567)
111. Leon LA, McKinley MJ, McAllen RM, May CN. Aldosterone acts on the kidney, not the brain, to cause mineralocorticoid hypertension in sheep. J Hypertens 20: 1203-1208, 2002.
112. Lu J, Sherman D, Devor M, Saper CB. A putative flip-flop switch for control of REM sleep. Nature 441: 589-594, 2006. (Pubitemid 43927285)
113. Luiten PG, ter Horst GJ, Karst H, Steffens AB. The course of paraventricular hypothalamic efferents to autonomic structures in medulla and spinal cord. Brain Res 329: 374-378, 1985.
114. MacKenzie SM, Clark CJ, Fraser R, Gomez-Sanchez CE, Connell JM, Davies E. Expression of 11β-hydroxylase and aldosterone synthase genes in the rat brain. J Mol Endocrinol 24: 321-328, 2000. (Pubitemid 30415006)
115. MacKenzie SM, Dewar D, Stewart W, Fraser R, Connell JM, Davies E. The transcription of steroidogenic genes in the human cerebellum and hippocampus: a comparative survey of normal and Alzheimer's tissue. J Endocrinol 196: 123-130, 2008. (Pubitemid 351234577)
116. Malinow KC, Lion JR. Hyperaldosteronism (Conn's disease) presenting as depression. J Clin Psychiatry 40: 358-359, 1979.
117. Mattsson C, Young WF Jr. Primary aldosteronism: diagnostic and treatment strategies. Nat Clin Pract Nephrol 2: 198-208; quiz, 191 p following 230, 2006. (Pubitemid 43787286)
118. McCance RA. Experimental human salt deficiency. Lancet 1: 823-830, 1936.
119. Mendelsohn FA, Quirion R, Saavedra JM, Aguilera G, Catt KJ. Autoradiographic localization of angiotensin II receptors in rat brain. Proc Natl Acad Sci USA 81: 1575-1579, 1984.
120. Mercer WR, Krozowski ZS. Localization of an 11β-hydroxysteroid dehydrogenase activity to the distal nephron. Evidence for the existence of two species of dehydrogenase in the rat kidney. Endocrinology 130: 540-543, 1992.
121. Moisan MP, Edwards CR, Seckl JR. Ontogeny of 11β-hydroxysteroid dehydrogenase in rat brain and kidney. Endocrinology 130: 400-404, 1992.
122. Moisan MP, Seckl JR, Edwards CR. 11β-Hydroxysteroid dehydrogenase bioactivity and messenger RNA expression in rat forebrain: localization in hypothalamus, hippocampus, and cortex. Endocrinology 127: 1450-1455, 1990.
123. Morris MJ, Na ES, Grippo AJ, Johnson AK. The effects of deoxycorticosterone- induced sodium appetite on hedonic behaviors in the rat. Behav Neurosci 120: 571-579, 2006.
124. Murck H, Held K, Ziegenbein M, Kunzel H, Koch K, Steiger A. The renin-angiotensin-aldosterone system in patients with depression compared to controls - a sleep endocrine study. BMC Psychiatry 3: 15, 2003. (Pubitemid 38729340)
125. Naray-Fejes-Toth A, Colombowala IK, Fejes-Toth G. The role of 11β-hydroxysteroid dehydrogenase in steroid hormone specificity. J Steroid Biochem Mol Biol 65: 311-316, 1998. (Pubitemid 28335618)
126. Naray-Fejes-Toth A, Fejes-Toth G. Novel mouse strain with Cre recombinase in 11β-hydroxysteroid dehydrogenase-2-expressing cells. Am J Physiol Renal Physiol 292: F486-F494, 2007. (Pubitemid 46105287)
127. Naray-Fejes-Toth A, Rusvai E, Denault DL, St Germain DL, Fejes- Toth G. Expression and characterization of a new species of 11β- hydroxysteroid dehydrogenase in Xenopus oocytes. Am J Physiol Renal Fluid Electrolyte Physiol 265: F896-F900, 1993. (Pubitemid 24027599)
128. Naray-Fejes-Toth A, Watlington CO, Fejes-Toth G. 11β-Hydroxysteroid dehydrogenase activity in the renal target cells of aldosterone. Endocrinology 129: 17-21, 1991.
129. Noguchi KK, Walls KC, Wozniak DF, Olney JW, Roth KA, Farber NB. Acute neonatal glucocorticoid exposure produces selective and rapid cerebellar neural progenitor cell apoptotic death. Cell Death Differ 15: 1582-1592, 2008.
130. Norgren R, Smith GP. Central distribution of subdiaphragmatic vagal branches in the rat. J Comp Neurol 273: 207-223, 1988. (Pubitemid 18178187)
131. Oldendorf WH. Measurement of brain uptake of radiolabeled substances using a tritiated water internal standard. Brain Res 24: 372-376, 1970.
132. Orlov SN, Mongin AA. Salt-sensing mechanisms in blood pressure regulation and hypertension. Am J Physiol Heart Circ Physiol 293: H2039-H2053, 2007. (Pubitemid 47605848)
133. Palkovits M, Monos E, Fachet J. The effect of subcommissural-organ lesions on aldosterone production in the rat. Acta Endocrinol 48: 169-176, 1965.
134. Pardridge WM. Transport of protein-bound hormones into tissues in vivo. Endocr Rev 2: 103-123, 1981.
135. Pardridge WM, Mietus LJ. Regional blood-brain barrier transport of the steroid hormones. J Neurochem 33: 579-581, 1979. (Pubitemid 9240949)
136. Pardridge WM, Mietus LJ. Transport of protein-bound steroid hormones into liver in vivo. Am J Physiol Endocrinol Metab Gastrointest Physiol 237: E367-E372, 1979. (Pubitemid 10194513)
137. Pardridge WM, Mietus LJ. Transport of steroid hormones through the rat blood-brain barrier. Primary role of albumin-bound hormone. J Clin Invest 64: 145-154, 1979. (Pubitemid 9216529)
138. Parker RB, Yates CR, Laizure SC, Weber KT. P-glycoprotein modulates aldosterone plasma disposition and tissue uptake. J Cardiovasc Pharmacol 47: 55-59, 2006.
139. Pennington GL, McKinley MJ. Reduction of cerebral NaCl concentration can abolish mineralocorticoid escape. Am J Physiol Renal Fluid Electrolyte Physiol 259: F839-F846, 1990.
140. Pfaff D, Keiner M. Atlas of estradiol-concentrating cells in the central nervous system of the female rat. J Comp Neurol 151: 121-158, 1973.
141. Picketts DJ. Neuropeptide signaling and hydrocephalus: SCO with the flow. J Clin Invest 116: 1828-1832, 2006.
142. Rahmouni K, Barthelmebs M, Grima M, Imbs JL, De Jong W. Influence of sodium intake on the cardiovascular and renal effects of brain mineralocorticoid receptor blockade in normotensive rats. J Hypertens 20: 1829-1834, 2002.
143. Rajan V, Edwards CR, Seckl JR. 11β-Hydroxysteroid dehydrogenase in cultured hippocampal cells reactivates inert 11-dehydrocorticosterone, potentiating neurotoxicity. J Neurosci 16: 65-70, 1996. (Pubitemid 2620358)
144. Reul JM, de Kloet ER. Two receptor systems for corticosterone in rat brain: microdistribution and differential occupation. Endocrinology 117: 2505-2511, 1985.
145. Rice KK, Richter CP. Increased sodium chloride and water intake of normal rats treated with desoxycorticosterone acetate. Endocrinology 33: 106-115, 1943.
146. Robel P, Baulieu EE. Neurosteroids. Biosynthesis and function. Trends Endocrinol Metab 5: 1-8, 1994.
147. Robson AC, Leckie CM, Seckl JR, Holmes MC. 11β-Hydroxysteroid dehydrogenase type 2 in the postnatal and adult rat brain. Brain Res Mol Brain Res 61: 1-10, 1998. (Pubitemid 28511343)
148. Roland BL, Krozowski ZS, Funder JW. Glucocorticoid receptor, mineralocorticoid receptors, 11β-hydroxysteroid dehydrogenase-1 and -2 expression in rat brain and kidney: in situ studies. Mol Cell Endocrinol 111: R1-R7, 1995.
149. Roland BL, Li KX, Funder JW. Hybridization histochemical localization of 11β-hydroxysteroid dehydrogenase type 2 in rat brain. Endocrinology 136: 4697-4700, 1995.
150. Sagar SM, Sharp FR, Curran T. Expression of c-Fos protein in brain: metabolic mapping at the cellular level. Science 240: 1328-1331, 1988. (Pubitemid 18155914)
151. Sakai RR, Nicolaidis S, Epstein AN. Salt appetite is suppressed by interference with angiotensin II and aldosterone. Am J Physiol Regul Integr Comp Physiol 251: R762-R768, 1986. (Pubitemid 17168214)
152. Schweimer J, Fendt M, Schnitzler HU. Effects of clonidine injections into the bed nucleus of the stria terminalis on fear and anxiety behavior in rats. Eur J Pharmacol 507: 117-124, 2005. (Pubitemid 40126847)
153. Seckl JR. 11β-Hydroxysteroid dehydrogenase in the brain: a novel regulator of glucocorticoid action? Front Neuroendocrinol 18: 49-99, 1997. (Pubitemid 27045165)
154. Sequeira SM, Geerling JC, Loewy AD. Local inputs to aldosterone-sensitive neurons of the nucleus tractus solitarius. Neuroscience 141: 1995-2005, 2006.
155. Shekhtman E, Geerling JC, Loewy AD. Aldosterone-sensitive neurons of the nucleus of the solitary tract: multisynaptic pathway to the nucleus accumbens. J Comp Neurol 501: 274-289, 2007. (Pubitemid 46233334)
156. Sheppard KE, Funder JW. Equivalent affinity of aldosterone and corticosterone for type I receptors in kidney and hippocampus: direct binding studies. J Steroid Biochem 28: 737-742, 1987.
157. Shin JW, Geerling JC, Loewy AD. Inputs to the ventrolateral bed nucleus of the stria terminalis. J Comp Neurol 511: 628-657, 2008.
158. Shin JW, Geerling JC, Loewy AD. Vagal innervation of the aldosterone-sensitive HSD2 neurons in the NTS. Brain Res 1249: 135-147, 2009.
159. Sonino N, Fallo F, Fava GA. Psychological aspects of primary aldosteronism. Psychother Psychosom 75: 327-330, 2006.
160. Soontornmalai A, Vlaming ML, Fritschy JM. Differential, strain-specific cellular and subcellular distribution of multidrug transporters in murine choroid plexus and blood-brain barrier. Neuroscience 138: 159-169, 2006. (Pubitemid 43222078)
161. Stewart PM, Corrie JE, Shackleton CH, Edwards CR. Syndrome of apparent mineralocorticoid excess. A defect in the cortisol-cortisone shuttle. J Clin Invest 82: 340-349, 1988.
162. Stewart PM, Wallace AM, Valentino R, Burt D, Shackleton CH, Edwards CR. Mineralocorticoid activity of liquorice: 11β-hydroxysteroid dehydrogenase deficiency comes of age. Lancet 2: 821-824, 1987. (Pubitemid 17144774)
163. Stricker EM, Thiels E, Verbalis JG. Sodium appetite in rats after prolonged dietary sodium deprivation: a sexually dimorphic phenomenon. Am J Physiol Regul Integr Comp Physiol 260: R1082-R1088, 1991.
164. Stromstedt M, Waterman MR. Messenger RNAs encoding steroido-genic enzymes are expressed in rodent brain. Brain Res Mol Brain Res 34: 75-88, 1995.
165. Sullivan MJ, Hasser EM, Moffitt JA, Bruno SB, Cunningham JT. Rats exhibit aldosterone-dependent sodium appetite during 24 h hindlimb unloading. J Physiol 557: 661-670, 2004.
166. Ueda K, Okamura N, Hirai M, Tanigawara Y, Saeki T, Kioka N, Komano T, Hori R. Human P-glycoprotein transports cortisol, aldosterone, and dexamethasone, but not progesterone. J Biol Chem 267: 24248-24252, 1992.
167. Uhr M, Holsboer F, Muller MB. Penetration of endogenous steroid hormones
168. Ulick S, Levine LS, Gunczler P, Zanconato G, Ramirez LC, Rauh W, Rosler A, Bradlow HL, New MI. A syndrome of apparent mineralocorticoid excess associated with defects in the peripheral metabolism of cortisol. J Clin Endocrinol Metab 49: 757-764, 1979. (Pubitemid 10198311)
169. Vallee SM, Grillo CA, Gonzalez S, Cosen-Binker L, de Kloet ER, McEwen BS, De Nicola AF. Further studies in deoxycorticosterone acetate treated rats: brain content of mineralocorticoid and glucocorticoid receptors and effect of steroid antagonists on salt intake. Neuroendocrinology 61: 117-124, 1995.
170. Van den Berg DT, de Jong W, de Kloet ER. Mineralocorticoid antagonist inhibits stress-induced blood pressure response after repeated daily warming. Am J Physiol Endocrinol Metab 267: E921-E926, 1994.
171. Van den Berg DT, de Kloet ER, de Jong W. Central effects of mineralocorticoid antagonist RU-28318 on blood pressure of DOCA-salt hypertensive rats. Am J Physiol Endocrinol Metab 267: E927-E933, 1994.
172. van den Berg DT, de Kloet ER, van Dijken HH, de Jong W. Differential central effects of mineralocorticoid and glucocorticoid agonists and antagonists on blood pressure. Endocrinology 126: 118-124, 1990.
173. van Eekelen JA, Bohn MC, de Kloet ER. Postnatal ontogeny of mineralocorticoid and glucocorticoid receptor gene expression in regions of the rat tel- and diencephalon. Brain Res Dev Brain Res 61: 33-43, 1991.
174. Veldhuis HD, De Kloet ER. Antagonistic effects of aldosterone on corticosterone-mediated changes in exploratory behavior of adrenalectomized rats. Horm Behav 17: 225-232, 1983.
175. Wang VY, Rose MF, Zoghbi HY. Math1 expression redefines the rhombic lip derivatives and reveals novel lineages within the brainstem and cerebellum. Neuron 48: 31-43, 2005.
176. Wang W. Chronic administration of aldosterone depresses baroreceptor reflex function in the dog. Hypertension 24: 571-575, 1994. (Pubitemid 24337826)
177. Wang X, Cen X, Lu L. Noradrenaline in the bed nucleus of the stria terminalis is critical for stress-induced reactivation of morphine-conditioned place preference in rats. Eur J Pharmacol 432: 153-161, 2001. (Pubitemid 34003596)
178. Webb DJ, Clark SA, Brown WB, Fraser R, Lever AF, Murray GD, Robertson JI. Dietary sodium deprivation raises blood pressure in the rat but does not produce irreversible hyperaldosteronism. J Hypertens 5: 525-531, 1987.
179. Weindl A, Joynt RJ. Barrier properties of the subcommissural organ. Arch Neurol 29: 16-22, 1973.
180. Weston M, Wang H, Stornetta RL, Sevigny CP, Guyenet PG. Fos expression by glutamatergic neurons of the solitary tract nucleus after phenylephrine-induced hypertension in rats. J Comp Neurol 460: 525-541, 2003. (Pubitemid 36528660)
181. Wolf G. Sodium appetite elicited by aldosterone. Psychon Sci 1: 211-212, 1964.
182. Wolf G. Effect of deoxycorticosterone on sodium appetite of intact and adrenalectomized rats. Am J Physiol 208: 1281-1285, 1965.
183. Wolf G, Handal PJ. Aldosterone-induced sodium appetite: dose-response and specificity. Endocrinology 78: 1120-1124, 1966.
184. Ye P, Kenyon CJ, Mackenzie SM, Nichol K, Seckl JR, Fraser R, Connell JM, Davies E. Effects of ACTH, dexamethasone, and adrenalectomy on 11β-hydroxylase (CYP11B1) and aldosterone synthase (CYP11B2) gene expression in the rat central nervous system. J Endocrinol 196: 305-311, 2008. (Pubitemid 351298515)
185. Ye P, Kenyon CJ, MacKenzie SM, Seckl JR, Fraser R, Connell JM, Davies E. Regulation of aldosterone synthase gene expression in the rat adrenal gland and central nervous system by sodium and angiotensin II. Endocrinology 144: 3321-3328, 2003. (Pubitemid 36904406)
186. Yee KM, Struthers AD. Aldosterone blunts the baroreflex response in man. Clin Sci (Lond) 95: 687-692, 1998.
187. Yongue BG, Roy EJ. Endogenous aldosterone and corticosterone in brain cell nuclei of adrenal-intact rats: regional distribution and effects of physiological variations in serum steroids. Brain Res 436: 49-61, 1987.
188. Yoshida K, McCormack S, Espana RA, Crocker A, Scammell TE. Afferents to the orexin neurons of the rat brain. J Comp Neurol 494: 845-861, 2005. (Pubitemid 43054230)
189. Yu L, Romero DG, Gomez-Sanchez CE, Gomez-Sanchez EP. Steroidogenic enzyme gene expression in the human brain. Mol Cell Endocrinol 190: 9-17, 2002. (Pubitemid 34462048)
190. Yu Y, Wei SG, Zhang ZH, Gomez-Sanchez E, Weiss RM, Felder RB. Does aldosterone upregulate the brain renin-angiotensin system in rats with heart failure? Hypertension 51: 727-733, 2008. (Pubitemid 351301527)
191. Zhang ZH, Francis J, Weiss RM, Felder RB. The renin-angiotensin- aldosterone system excites hypothalamic paraventricular nucleus neurons in heart failure. Am J Physiol Heart Circ Physiol 283: H423-H433, 2002. (Pubitemid 34705366)
192. Zhang ZH, Kang YM, Yu Y, Wei SG, Schmidt TJ, Johnson AK, Felder RB. 11β-Hydroxysteroid dehydrogenase type 2 activity in hypothalamic paraventricular nucleus modulates sympathetic excitation. Hypertension 48: 127-133, 2006. (Pubitemid 44297534)
193. Zhou MY, Gomez-Sanchez EP, Cox DL, Cosby D, Gomez-Sanchez CE. Cloning, expression, and tissue distribution of the rat nicotinamide adenine dinucleotide-dependent 11β-hydroxysteroid dehydrogenase. Endocrinology 136: 3729-3734, 1995.